Ablatherm Integrated Imaging High Intensity Focused Ultrasound
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ablatherm Integrated Imaging High Intensity Focused Ultrasound, covering 2014-02-07 to 2014-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer [Phase 2, Phase 3]